Sofia, Bulgaria, November 7, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for October 2022 the Company recorded a increase in sales of 30% compared to the same month of the previous year, incl. 13% decrease in domestic sales and 58% increase in export sales.

For the ten months since the beginning of the year the revenues from sales of products increase by 19%, incl. 12% increase of sales for the domestic market and 23% increase in export sales.